Testing a noninvasive Synacthen test in kids and healthy adults
Part of Hormones & metabolism clinical trials.
This trial studies how well a short, noninvasive Synacthen test works in people at different ages, including children with asthma. It’s meant to safely measure how the body responds to a hormone signal without needing more invasive testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) are in the right age group for one study group: adult (18–64) or child (0–18, or 2–15 depending on group)
- You are generally healthy if you’re in the “healthy” groups, or you have asthma if you’re in the asthma group
- You are not using any medications at the time of the test (or weren’t recently using corticosteroids)
- No history of hormone gland problems, and no history of serious adrenal, kidney, or brain-related hormone problems
- No past allergic reaction to ACTH or Synacthen, and no history of severe allergic reactions
- No recent cold/nose symptoms in the last week, and you are not a current smoker
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether updated cortisol test numbers better identify adrenal insufficiency, a hormone condition where your body doesn’t make enough stress hormone. It may help doctors confirm the diagnosis and choose safer next steps for treatment.
This trial tests if a hormone called ACTH can help children with nephrotic syndrome who have frequent relapses or need steroids to stay in remission. It aims to find a treatment that may reduce the need for steroids and prevent relapses.
This study tests a new medication called ASY202 for adults with stable asthma. The goal is to see if it's safe and how the body processes it. It may be an option for those who have not had a recent asthma attack or infection.
This study tests an inhaled medication called SYH2059 to see how safe it is and how the body processes it. It is for healthy adults and involves taking the drug once or multiple times to measure its effects.
This trial tests a new drug called ADO-5030 in people with mild to moderate asthma to see how it affects their airway sensitivity. Participants will have breathing tests using AMP (a substance that can trigger asthma-like symptoms) to measure the drug's effects.
This trial is testing a new method (using a blood test that measures steroid hormones) to better diagnose whether adrenal nodules are causing mild hormone problems. It may help doctors decide if you need treatment or just monitoring.
Hear when a new Adrenal Suppression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.